These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12533161)

  • 1. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression.
    Bachot N; Revuz J; Roujeau JC
    Arch Dermatol; 2003 Jan; 139(1):33-6. PubMed ID: 12533161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
    Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
    J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Mittmann N; Chan B; Knowles S; Cosentino L; Shear N
    Am J Clin Dermatol; 2006; 7(6):359-68. PubMed ID: 17173470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.
    Lee HY; Lim YL; Thirumoorthy T; Pang SM
    Br J Dermatol; 2013 Dec; 169(6):1304-9. PubMed ID: 24007192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Khalili B; Bahna SL
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
    French LE; Trent JT; Kerdel FA
    Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
    J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience.
    Trent JT; Kirsner RS; Romanelli P; Kerdel FA
    Arch Dermatol; 2003 Jan; 139(1):39-43. PubMed ID: 12533162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulins in the treatment of toxic epidermal necrolysis: an Asian series.
    Tan AW; Thong BY; Yip LW; Chng HH; Ng SK
    J Dermatol; 2005 Jan; 32(1):1-6. PubMed ID: 15841652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality.
    Aires DJ; Fraga G; Korentager R; Richie CP; Aggarwal S; Wick J; Liu DY
    J Drugs Dermatol; 2013 Jun; 12(6):679-84. PubMed ID: 23839186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens Johnson syndrome and toxic epidermal necrolysis - an Australian analysis of treatment outcomes and mortality.
    Tran AK; Sidhu S
    J Dermatolog Treat; 2019 Nov; 30(7):718-723. PubMed ID: 30632424
    [No Abstract]   [Full Text] [Related]  

  • 15. Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Valeyrie-Allanore L; Wolkenstein P; Brochard L; Ortonne N; Maître B; Revuz J; Bagot M; Roujeau JC
    Br J Dermatol; 2010 Oct; 163(4):847-53. PubMed ID: 20500799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.
    Chan L; Cook DK
    Int J Dermatol; 2019 Oct; 58(10):1141-1147. PubMed ID: 30908601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases.
    Prins C; Kerdel FA; Padilla RS; Hunziker T; Chimenti S; Viard I; Mauri DN; Flynn K; Trent J; Margolis DJ; Saurat JH; French LE;
    Arch Dermatol; 2003 Jan; 139(1):26-32. PubMed ID: 12533160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
    Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
    J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies.
    Barron SJ; Del Vecchio MT; Aronoff SC
    Int J Dermatol; 2015 Jan; 54(1):108-15. PubMed ID: 24697283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.